Tanya J. Uritsky, PharmD, BCPP, FPPCP, FASHP, discusses multimodal analgesia, acute pain pathways, opioid-tolerant patients, suzetrigine, and pharmacist-led interventions across health systems with Pharmacy Times.
Tanya J. Uritsky, PharmD, BCPP
Advertisement
Articles by Tanya J. Uritsky, PharmD, BCPP
Using the term "pseudodementia" contributes to the mismanagement and mistreatment of the disease.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know
2
FDA Approves First OTC Acetaminophen-Naproxen Combination for 12-Hour Pain Relief
3
What Real-World Data Show About Moving Patients From Humira to Biosimilars
4
New Review Offers Framework for Sequencing Disease-Modifying Therapies in MS
5